Perspective Therapeutics, Inc. Common Stock (NY:CATX)

2.360 -0.210 (-8.17%)

Official Closing Price Updated: 8:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Perspective Therapeutics, Inc. Common Stock

< Previous 1 2 3 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 05, 2023

Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 20, 2023

Via Benzinga

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Via Benzinga

Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 73.5% to $0.1313 in pre-market trading after falling 15% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 19, 2023

Pre-market stock movers are a hot topic on Tuesday as investors seek out the latest news on the biggest traders this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 18, 2023

Via Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 18, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 18, 2023

Via Benzinga

Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket ↗

September 18, 2023

Gainers T2 Biosystems, Inc. (NASDAQ: TTOO) shares rose 44.4% to $0.4003 in pre-market trading. T2 Biosystems said it issued inducement awards to four new employees.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 16, 2023

Via Benzinga

The Best Penny Stock to Buy Now ZH vs CATX vs LMFA ↗

May 28, 2023

If you don’t mind exchanging downside risk for massive upside possibilities, these are your choices for best penny stock to buy now.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 10, 2023

Via Benzinga

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 16, 2023

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 24, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 24, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 10, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.